Seer Inc (SEER)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $87.63M
Last updated: Nov 17, 2026 at 11:06 AM ET
Seer Inc (SEER) Competitors
The companies most similar to SEER are Coherus BioSciences (CHRS), Equillium (EQ) and PDS Biotechnology (PDSB). By market cap, SEER ranks 7th of the 13 companies on this page; Codexis (CDXS) is the largest at $127.13M.
Peer Comparison
SEER's revenue growth of -3.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Seer (SEER) | $87.63M | N/A | 5.8x | 0.0% | N/A | -3.4% | 0.00% |
| Coherus BioSciences Inc (CHRS) | $81.21M | N/A | 1.5x | -253.4% | -144.8% | 23.4% | 0.00% |
| Equillium Inc (EQ) | $106.20M | N/A | 29.3x | 0.0% | N/A | -52.3% | 0.00% |
| PDS Biotechnology Corp (PDSB) | $107.07M | N/A | N/A | 0.0% | -149.8% | 0.0% | 0.00% |
| Gossamer Bio Inc (GOSS) | $67.10M | N/A | 0.9x | -159.5% | 147.4% | 189.1% | 0.00% |
| Spero Therapeutics Inc (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| iBio, Inc. Common Stock (IBIO) | $51.55M | N/A | 735.4x | 0.0% | N/A | 975.0% | 0.00% |
| Anixa Biosciences Inc (ANIX) | $91.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| Codexis Inc (CDXS) | $127.13M | N/A | N/A | -21.8% | N/A | 124.0% | 0.00% |
| Minerva Neurosciences Inc (NERV) | $114.62M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pmv Pharmaceuticals Inc (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $86.15M | 11.1x | 1.5x | 0.0% | -109.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Seer, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Coherus BioSciences Inc (CHRS) | Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. | CHRS competitors |
| Equillium Inc (EQ) | Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory... | EQ competitors |
| PDS Biotechnology Corp (PDSB) | PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. | PDSB competitors |
| Gossamer Bio Inc (GOSS) | Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing... | GOSS competitors |
| Spero Therapeutics Inc (SPRO) | Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing... | SPRO competitors |
| iBio, Inc. Common Stock (IBIO) | iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. | IBIO competitors |
| Anixa Biosciences Inc (ANIX) | Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. | ANIX competitors |
| Heron Therapeuti (HRTX) | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. | HRTX competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| Codexis Inc (CDXS) | Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California. | CDXS competitors |
| Minerva Neurosciences Inc (NERV) | Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products... | NERV competitors |
| Pmv Pharmaceuticals Inc (PMVP) | PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53... | PMVP competitors |
Frequently Asked Questions About SEER
Who are SEER's main competitors?
The companies most similar to SEER include Coherus BioSciences (CHRS), Equillium (EQ), PDS Biotechnology (PDSB), Gossamer Bio (GOSS) and Spero Therapeutics (SPRO), listed from the closest match.
Who is SEER's biggest competitor?
Codexis (CDXS) is the largest of the similar companies at $127.13M; Coherus BioSciences (CHRS) is the closest match by business profile, size, sector and industry.
How does SEER stock compare with its competitors?
SEER's P/S is 5.8x against a peer median of 1.5x; its net margin is 0.0% against a peer median of 0.0%.
Which of SEER's competitors pays a higher dividend?
SEER pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is SEER bigger than its competitors?
No. SEER is 7th by market cap among the 13 companies on this page; the largest is Codexis (CDXS) at $127.13M.
SEER pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts